H.C. Wainwright Downgrades FibroGen (FGEN) to Neutral
Tweet
Share
E-mailGet Alerts FGEN Hot Sheet
Price: $1.02 +4.08%
Rating Summary:
3 Buy, 9 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 9 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
H.C. Wainwright analyst Edwin Zhang downgraded FibroGen (NASDAQ: FGEN) from Buy to Neutral.
For an analyst ratings summary and ratings history on FibroGen click here. For more ratings news on FibroGen click here.
Shares of FibroGen closed at $25.90 yesterday.
You May Also Be Interested In
- JPMorgan Downgrades Monster Beverage (MNST) to Neutral, 'Cost Pressures and Weaker Low-end Consumer'
- Leerink Partners Downgrades CureVac (CVAC) to Market Perform
- Nomura/Instinet Downgrades ICICI Prudential Life Insurance Co Ltd. (IPRU:IN) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
